Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, (2019) American association of clinical endocrinologists and American college of endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract 25:1191–1232

Article  PubMed  Google Scholar 

Melmed S (2019) Pathogenesis and diagnosis of growth hormone Deficiency in adults. N Engl J Med 380:2551–2562

Article  PubMed  CAS  Google Scholar 

Giovannini L, Tirabassi G, Muscogiuri G, Di Somma C, Colao A et al (2015) Impact of adult growth hormone deficiency on metabolic profile and cardiovascular risk [Review]. Endocr J 62:1037–1048

Article  PubMed  CAS  Google Scholar 

Jørgensen JOL, Juul A (2018) Therapy of endocrine disease: growth hormone replacement therapy in adults: 30 years of personal clinical experience. Eur J Endocrinol 179:R47–R56

Article  PubMed  Google Scholar 

Svensson J, Mattsson A, Rosén T, Wirén L, Johannsson G et al (2004) Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption. Growth Horm IGF Res 14:207–215

Article  PubMed  CAS  Google Scholar 

Ishii H, Shimatsu A, Nishinaga H, Murai O, Chihara K (2017) Assessment of quality of life on 4-year growth hormone therapy in Japanese patients with adult growth hormone deficiency: a post-marketing, multicenter, observational study. Growth Horm IGF Res 36:36–43

Article  PubMed  Google Scholar 

Zhou H, Sun L, Zhang S, Wang Y, Wang G (2021) Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis. Pituitary 24:130–142

Article  PubMed  CAS  Google Scholar 

Ratku B, Sebestyén V, Erdei A, Nagy EV, Szabó Z et al (2022) Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile. Pituitary 25:211–228

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shen Y-Y, Ma J-N, Ren Z-Y, Liu J, Zhou X-Y et al (2023) Effects of 18 Months of Growth Hormone Replacement Therapy on Bone Mineral Density in Patients with Adult Growth Hormone Deficiency: A Retrospective Study. Int J Endocrinol 2023:4988473

Johannsson G, Touraine P, Feldt-Rasmussen U, Pico A, Vila G et al (2022) Long-term safety of growth hormone in adults with growth hormone Deficiency: overview of 15 809 GH-Treated patients. J Clin Endocrinol Metab 107:1906–1919

Article  PubMed  PubMed Central  Google Scholar 

Elbornsson M, Götherström G, Bosæus I, Bengtsson B-Å, Johannsson G et al (2013) Fifteen years of GH replacement improves body composition and cardiovascular risk factors. Eur J Endocrinol 168:745–753

Article  PubMed  PubMed Central  CAS  Google Scholar 

Losa M, Castellino L, Pagnano A, Rossini A, Mortini P et al (2020) Growth hormone therapy does not increase the risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma recurrence. J Clin Endocrinol Metab 105

van Varsseveld NC, van Bunderen CC, Franken AAM, Koppeschaar HPF, van der Lely AJ et al (2015) Tumor recurrence or regrowth in adults with nonfunctioning Pituitary Adenomas using GH replacement therapy. J Clin Endocrinol Metab 100:3132–3139

Article  PubMed  Google Scholar 

Kinoshita Y, Yamasaki F, Taguchi A, Takayasu T, Yonezawa U et al (2022) Influence of growth hormone therapy on germinoma survivors. Pituitary 25:854–860

Article  PubMed  CAS  Google Scholar 

Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH et al (2016) Hormonal replacement in hypopituitarism in adults: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101:3888–3921

Article  PubMed  CAS  Google Scholar 

Arima H, Otsuki M, Kageyama K, Takahashi Y, Tahara S et al (2023) Guidelines for the treatment of hypothalamic and pituitary dysfunction and Congenital Nephrolithiasis and Related disorders, 2023 Edition. Folia Endocrinol Japonica 99(Suppl):1–171 (In Japanese)

Google Scholar 

Suzuki S, Ruike Y, Ishiwata K, Naito K, Igarashi K et al (2022) Clinical usefulness of the growth hormone-releasing Peptide-2 test for hypothalamic-pituitary disorder. J Endocr Soc 6:bvac088

Article  PubMed  PubMed Central  Google Scholar 

Shimatsu A, Tai S, Tanaka T, Fujieda K, Teramoto A et al (2011) Clinical characteristics of Japanese adults with growth hormone deficiency: a HypoCCS database study. Endocr J 58:325–333

Article  PubMed  CAS  Google Scholar 

Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T et al (2012) Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J 59:771–780

Article  PubMed  CAS  Google Scholar 

Kanda Y (2013) Investigation of the freely available easy-to-use software EZR for medical statistics. Bone Marrow Transpl 48:452–458

Article  CAS  Google Scholar 

Götherström G, Bengtsson B-A, Bosaeus I, Johannsson G, Svensson J (2007) A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. J Clin Endocrinol Metab 92:1442–1445

Article  PubMed  Google Scholar 

Claessen KMJA, Appelman-Dijkstra NM, Adoptie DMMM, Roelfsema F, Smit JWA et al (2013) Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy. J Clin Endocrinol Metab 98:352–361

Article  PubMed  CAS  Google Scholar 

Biller BMK, Höybye C, Ferran J-M, Kelepouris N, Nedjatian N et al (2023) Long-term effectiveness and safety of GH replacement therapy in adults ≥ 60 years: data from NordiNet® IOS and ANSWER. J Endocr Soc 7:bvad054

Article  PubMed  PubMed Central  Google Scholar 

Zhang S, Li Z, Lv Y, Sun L, Xiao X et al (2020) Cardiovascular effects of growth hormone (GH) treatment on GH-deficient adults: a meta-analysis update. Pituitary 23:467–475

Article  PubMed  CAS  Google Scholar 

Scarano E, Riccio E, Somma T, Arianna R, Romano F et al (2021) Impact of long-term growth hormone replacement therapy on Metabolic and Cardiovascular parameters in adult growth hormone Deficiency: comparison between Adult and Elderly patients. Front Endocrinol 12:635983

Article  Google Scholar 

Luger A, Mattsson AF, Koltowska-Häggström M, Thunander M, Góth M et al (2012) Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study. Diabetes Care 35:57–62

Article  PubMed  CAS  Google Scholar 

Kong T, Gu Y, Sun L, Zhou R, Li J et al (2023) Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis. Endocr J 70:959–967

Article  PubMed  Google Scholar 

Matsumoto R, Fukuoka H, Iguchi G, Nishizawa H, Bando H et al (2014) Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency. Growth Horm IGF Res 24:174–179

Article  PubMed  CAS  Google Scholar 

Takahashi Y (2023) Nonalcoholic fatty liver disease and adult growth hormone deficiency: an under-recognized association? Best Pract Res Clin Endocrinol Metab 37:101816

Article  PubMed  CAS  Google Scholar 

Gardner CJ, Irwin AJ, Daousi C, McFarlane IA, Joseph F et al (2012) Hepatic steatosis, GH deficiency and the effects of GH replacement: a Liverpool magnetic resonance spectroscopy study. Eur J Endocrinol 166:993–1002

Article  PubMed  CAS  Google Scholar 

Carvalho-Furtado ACL, Carvalho-Louro DM, Regattieri NAT, Rodrigues MP, Montenegro MLRN et al (2019) Transient Elastography and controlled attenuation parameter (CAP) in the Assessment of Liver steatosis in severe adult growth hormone Deficiency. Front Endocrinol 10:364

Article  Google Scholar 

Appelman-Dijkstra NM, Claessen KMJA, Hamdy NAT, Pereira AM, Biermasz NR (2014) Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study. Clin Endocrinol (Oxf) 81:727–735

Article  PubMed  CAS  Google Scholar 

Elbornsson M, Götherström G, Bosæus I, Bengtsson B-Å, Johannsson G et al (2012) Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. Eur J Endocrinol 166:787–795

Article  PubMed  PubMed Central